Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David De Bels

Showing results (91-100 of 215) with videos related to

Pageof 22
Sort By:
Critical Care (London, England)|February 26, 2020
Thrombolytic therapy during resuscitation for pulmonary embolism-related out-of-hospital cardiac arrest: perhaps not the ideal solution for everyonePatrick M Honore, Cristina David, Aude Mugisha, et al.
Critical Care (London, England)|March 19, 2020
Endostatin shows a useful value for predicting failure to recover from acute kidney injury: some confounders to considerPatrick M Honore, Christina David, Aude Mugisha, et al.
Critical Care (London, England)|May 15, 2020
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agentsPatrick M Honore, Aude Mugisha, Luc Kugener, et al.
Critical Care (London, England)|April 11, 2020
Clostridioides difficile infection in the critically ill: what kind of therapy for refractory casesPatrick M Honore, Aude Mugisha, Luc Kugener, et al.
Critical Care (London, England)|May 10, 2020
Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to considerPatrick M Honore, Aude Mugisha, Luc Kugener, et al.
Journal of Translational Internal Medicine|April 19, 2019
Diagnosing Acute Respiratory Distress Syndrome with the Berlin Definition: Which Technical Investigations Should be the Best to Confirm it?Sebastien Redant, Jacques Devriendt, Ilaria Botta, et al.
Journal of Translational Internal Medicine|January 29, 2021
Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill PatientsSébastien Redant, Julien Vanderhulst, Evelyne Maillart, et al.
The American Journal of Emergency Medicine|August 3, 2010
Thrombolysis associated with LUCAS (Lund University Cardiopulmonary Assist System) as treatment of valve thrombosis resulting in cardiac arrestPhilippe Gottignies, Jacques Devriendt, Emmanuel Tran Ngoc, et al.
Critical Care (London, England)|April 18, 2020
Candida infections in severe acute pancreatitis: we need to do more in order to distinguish invasive infection from simple colonizationPatrick M Honore, Aude Mugisha, Luc Kugener, et al.
Critical Care (London, England)|October 10, 2020
Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to considerPatrick M Honore, Leonel Barreto Gutierrez, Luc Kugener, et al.
Pageof 22

Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
Critical Care (London, England)|February 26, 2020
Thrombolytic therapy during resuscitation for pulmonary embolism-related out-of-hospital cardiac arrest: perhaps not the ideal solution for everyonePatrick M Honore, Cristina David, Aude Mugisha, et al.
Critical Care (London, England)|March 19, 2020
Endostatin shows a useful value for predicting failure to recover from acute kidney injury: some confounders to considerPatrick M Honore, Christina David, Aude Mugisha, et al.
Critical Care (London, England)|May 15, 2020
The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agentsPatrick M Honore, Aude Mugisha, Luc Kugener, et al.
Critical Care (London, England)|April 11, 2020
Clostridioides difficile infection in the critically ill: what kind of therapy for refractory casesPatrick M Honore, Aude Mugisha, Luc Kugener, et al.
Critical Care (London, England)|May 10, 2020
Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to considerPatrick M Honore, Aude Mugisha, Luc Kugener, et al.
Journal of Translational Internal Medicine|April 19, 2019
Diagnosing Acute Respiratory Distress Syndrome with the Berlin Definition: Which Technical Investigations Should be the Best to Confirm it?Sebastien Redant, Jacques Devriendt, Ilaria Botta, et al.
Journal of Translational Internal Medicine|January 29, 2021
Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill PatientsSébastien Redant, Julien Vanderhulst, Evelyne Maillart, et al.
The American Journal of Emergency Medicine|August 3, 2010
Thrombolysis associated with LUCAS (Lund University Cardiopulmonary Assist System) as treatment of valve thrombosis resulting in cardiac arrestPhilippe Gottignies, Jacques Devriendt, Emmanuel Tran Ngoc, et al.
Critical Care (London, England)|April 18, 2020
Candida infections in severe acute pancreatitis: we need to do more in order to distinguish invasive infection from simple colonizationPatrick M Honore, Aude Mugisha, Luc Kugener, et al.
Critical Care (London, England)|October 10, 2020
Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to considerPatrick M Honore, Leonel Barreto Gutierrez, Luc Kugener, et al.
Pageof 22